PATENT CLAIM ANALYSIS

Application Number: 16076401
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["530", "387900"]

Abstract:
The present invention provides antibodies or antibody fragments binding to human IL-17C. In particular, it relates to antibodies or antibody fragments that have combined beneficial properties and are therefore useful for the treatment of humans having, for example, atopic dermatitis or psoriasis.

Claim (Index 10):
An antibody or antibody fragment according to  claim 1 , wherein said antibody or antibody fragment is a recombinant antibody or antibody fragment.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 96.0
- Lexical Diversity: 1.27027
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16058143', '10891972', '10564647', '15764918', '15058612']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7398486246610698
- 35 USC 102 Novelty (BERT): 0.7011097190063587
- Combined Prediction Score: 0.7359747340955988
- Mean Citation Score: 507.97095400000006
- Max Citation Score: 776.8428
- Similarity Product: 720.1362745811463

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test